Site Navigation
 
Homepage

Welcome

Committees

Topics

>> Scientific Program

Social Program

Registration

Instructions for posters and abstracts

Guidelines for presenters

Publication of papers

Young Scientists

Organised Tours

Accommodation

AusTox meeting and workshops

Trade & Sponsorship

Trade Booths

Sponsors

General Info

Travel Info

 
    TIAFT2003 PROGRAMME WITH WORKSHOPS
 
SummaryMonday 17Tuesday 18Wednesday 19Thursday 20Fri. 21 - Sat. 22Poster sessions



Wednesday, November 19

08.00-17.30  Registration
08.30-17.30  Poster Display 2 - Strad/Hunt/Delacombe rooms (Hilton)
08.30-17.30  Trade Displays - First Floor, Hilton hotel
 
08.30-10.00  ORAL SESSION 5
CLINICAL TOXICOLOGY & TDM - JOINT SESSION WITH IATDMCT
Chairpersons: Prof. Hans Maurer (Germany), Prof. Albert Fraser (Canada)
 
Paper 1  KINETIC PROFILES OF CANNABINOIDS IN HUMAN MILK. PRELIMINARY RESULTS OF A FRENCH COLLABORATIVE STUDY
P Mura*, F Witthuhn*, Mj Perez*, Jh Bourdon**, Y Papet*, M Leclaire**, J Arditti**
*Centre Hospitalier Universitaire, Poitiers, FRANCE; **Centre Hospitalier Universitaire, Marseille, FRANCE
Paper 2  URINARY EXCRETION PROFILES OF 11-NOR-9-CARBOXY-D9TETRAHYDRO-CANNABINOL-9-CARBOXYLIC ACID AND 11-HYDROXY-D9-THC: CANNABINOID METABOLITES TO CREATININE RATIO - STUDY IV
AD Fraser*,**, D Worth*
Toxicology Laboratory*, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia; Department of Pathology**, Dalhousie University, Halifax, Nova Scotia, CANADA
Paper 3  EVALUATION OF IMMUNALYSIS® ELISA ASSAYS FOR THE DETECTION OF DRUGS OF ABUSE IN POSTMORTEM BLOOD
DS Isenschmid, DM Patton, BR Hepler, CJ Schmidt
Office of the Wayne County Medical Examiner, Detroit, Michigan, USA
Paper 4  MECHANISM OF DESIGNER ADULTERANT INTERACTIONS WITH CANNABINOIDS IN URINE
JSC Tsai*, MA ElSohly**, S-F Tsai*, TP Murphy**
*Roche Diagnostics Corporation, Indianapolis, Indiana, USA; **ElSohly Laboratories, Oxford, Mississippi, USA
Paper 5  INVOLVEMENT OF HUMAN HEPATIC CYTOCHROME P450 ISOENZYMES IN THE METABOLISM OF THE AMPHETAMINE PRECURSOR DRUGS CLOBENZOREX AND MEFENOREX
T. Kraemer, M. Bossmann, F.T. Peters, L.D. Paul, D. Springer, R.F. Staack and H.H. Maurer
Department of Experimental and Clinical Toxicology, Institute of Pharmacology and Toxicology, University of Saarland, Homburg, GERMANY
Paper 6  EVALUATION OF THE IDS ONE-STEP ELISA KIT FOR THE DETECTION OF BUPRENORPHINE IN URINE, BLOOD AND HAIR SPECIMENS
V Cirimele, S Etienne, M Villain, B Ludes, P Kintz
Institut de Médecine Légale, F-67085 Strasbourg, FRANCE
Paper 7  CONFIRMATORY ANALYSIS FOR DRUGS OF ABUSE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
B Maralíkóva*,**, F Dussy***, W Weinmann**
*University of Pardubice, FCHT, Department of Analytical Chemistry, Pardubice, Czech Republic; **Institute of Forensic Medicine, Forensic Toxicology, University Hospital, Freiburg, GERMANY; ***Institute of Forensic Medicine, Forensic Chemistry and Toxicology, University of Basel, SWITZERLAND
 
 Questions and Answers
 
10.00-10.30  COFFEE/TEA BREAK AND INFORMAL POSTER SESSION
 
10.30-12.00  ORAL SESSION 6
VENOMS, TOXINS & HERBALS
Chairpersons: Prof. D. Uges (Netherlands), Prof. G. Lau (Singapore)
 
Paper 1  Key Note 5:
FORENSIC TOXICOLOGY - WHEN THE SNAKE MEETS THE LAW IN THE LAB
Dr Ken Winkel (Australia) - 25 minutes
 
Paper 2  SLIM 10" - SLIM CHANCE: A FATAL CASE OF HEPATIC FAILURE POSSIBLY INDUCED BY NITROSOFENFLURAMINE
G Lau, D Lo, CL Chan
Health Sciences Authority, SINGAPORE
Paper 3  THE OCCURRENCE OF MYCOTOXINS IN RURAL AFRICAN PEOPLE
MF Dutton*, PK Chelule**, D Pillay**, T Palanee**, AA Chuturgoon**
*Faculty of Health Sciences, Technikon Witwatersrand, Doornfontein, SOUTH AFRICA; **Department of Physiology, University of Natal, Congella, SOUTH AFRICA
Paper 4  PACIFIC SEDATIVE BEVERAGE - KAVA - USED AS A DRUG OF ABUSE: SIX RECENT CASE-REPORTS
Y Barguil*, F Tarbah**, E Choblet*, JY Charlot***, W Weinmann****, D Duhet*****, Th Daldrup***
*Biochemistry Laboratory; New Caledonia Territorial Hospital, Noumea, New Caledonia; **Institute of Legal Medicine, Heinrich-Heine University, Düsseldorf, GERMANY; ***Psychiatric Ward, Specialised Hospital, Noumea, New Caledonia; ****Institute of Legal Medicine, University Hospital Freiburg, GERMANY; *****French Institute of Research for the Development, Noumea, NEW CALEDONIA
Paper 6  DETECTION OF TOXIC ALKALOIDS BY LC-MS (ELECTRON IMPACT)
PA Steenkamp*, NM Harding*, F R van Heerden**, B-E van Wyk***
*Forensic Toxicology Research Unit, Johannesburg Forensic Chemistry Laboratory, Department of Health, South Africa; **Department of Chemistry and Biochemistry, Rand Afrikaans University, South Africa; ***Department of Botany, Rand Afrikaans University, SOUTH AFRICA
Paper 7  CANNABIS PRODUCTION AND SALES IN SWITZERLAND
W Bernhard, B Aebi, P Regenscheit, F Luginbühl
Institute of Legal Medicine, Bern, SWITZERLAND
 
 Questions and Answers
 
12.00-13.30  LUNCH BREAK AND INFORMAL POSTER SESSION
 
12.00-13.30  IATDMCT toxicology committee meeting
Hotham room (1st floor Hilton)
 
13.30-15.15  ORAL SESSION 7
GENERAL TOXICOLOGY
Chairpersons: Dr John Lewis (Australia), Dr Anya Pierce (Ireland)
 
Paper 1  Key Note 6:
CURRENT DEVELOPMENTS IN SOLID PHASE EXTRACTION
Dr Nigel Simpson (Australia) - 20 min
Varian Australia, Mulgrave, Victoria, AUSTRALIA
 
Paper 2  PATCH TEST AND WIPE TEST FOR ALCOHOL MISUSE BASED ON THE CONCENTRATION RATIO OF FATTY ACID ETHYL ESTERS AND SQUALENE CFAEE/CSQ IN SEBUM
F Pragst, V Auwärter, B Kießling, C Dyes
Institute of Legal Medicine, Humboldt-University, Berlin, GERMANY
Paper 3  EVALUATION OF DRUG OF ABUSE ASSAYS USING BIOCHIP ARRAY TECHNOLOGY ON THE EVIDENCETM ANALYZER
PJ Orsulak, LC Akers, DC Fuller
Pathology & Laboratory Medicine Service, VA North Texas Health Care System, and Departments of Psychiatry and Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Paper 4  THE DEVELOPMENT OF A CAPILLARY ELECTROPHORESIS METHOD FOR THE CHIRAL SEPARATION OF METHADONE, AND IT'S TWO MAJOR METABOLITES, 2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHENYLPYRROLIDINE (EDDP) AND 2-ETHYL-5-METHYL-3,3-DIPHENYL-1-PYRROLINE (EMDP)
T Kelly, P Doble, M Dawson
Centre for Forensic Science, Faculty of Science, University of Technology, Sydney (UTS), Sydney, AUSTRALIA.
Paper 5  VALIDATION AND APPLICATION OF A GC-NICI-MS ASSAY FOR ENANTIOSELECTIVE DETERMINATION OF AMPHETAMINES IN ORAL FLUID
FT Peters*, N Samyn**, T Kraemer*, G De Boeck**, C Lamers***, and HH Maurer*
*Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Saarland, Homburg (Saar), GERMANY; **National Institute of Criminalistics and Criminology, Brussels, BELGIUM; ***Experimental Psychopharmacology Unit, Brain & Behaviour Institute, Maastricht University, Maastricht, THE NETHERLANDS
Paper 6  TESTING FOR A NIGHTMARE: GHB IN POSTMORTEM BLOOD
P Kintz, M Villain, V Cirimele, C Jamey, B Ludes
Institut de Médecine Légale, Strasbourg, FRANCE
Paper 7  SIMULTANEOUS ANALYSIS OF GHB AND PRECURSORS IN URINE USING LC-MS/MS
M Wood*, M Young**, N Samyn***, M Laloup***, M Morris* and G De Boeck***
*Waters Corporation MS Technologies Centre, Manchester, UK; **Waters Corporation, MA, USA; ***National Institute of Criminalistics and Criminology (NICC), Brussels, BELGIUM
Paper 8  INSTABILITY OF CALCIUM CHANNEL ANTAGONISTS DURING SAMPLE PREPARATION FOR LC-MS-MS ANALYSIS OF PLASMA SAMPLES
W Weinmann*, A B Baranda González *,**
*Institute of Forensic Medicine, Forensic Toxicology, University Hospital, Freiburg, GERMANY; **Departamento de Química Analítica, Facultad de Ciencias, Universidad del País Vasco, Bilbao, SPAIN
 
 Questions and Answers
 
15.15-15.45  TEA/COFFEE BREAK AND INFORMAL POSTER SESSION
 
15.45-17.30  ORAL SESSION 8
ALCOHOL, DRUGS & DRIVING
Chairpersons: Dr Barry Logan (USA), Dr Graham Jones (Canada)
 
Paper 1  Key Note 7:
EFFECT OF STIMULANTS ON ROAD USER BEHAVIOUR
Dr Barry Logan - 30 min
Washington State Patrol, Seattle, WA, USA
 
Paper 2  ILLICIT DRUGS, MEDICINAL DRUGS AND ALCOHOL IN DRIVERS IN SALZBURG AND UPPER AUSTRIA BEFORE AND AFTER THE REVISION OF THE ROAD TRAFFIC ACT
Th Keller, A Keller, E Tutsch-Bauer
Institute of Forensic Medicine, University of Salzburg, Ignaz-Harrer-Str. 79, 5020 Salzburg, AUSTRIA
Paper 3  METHADONE CONCENTRATIONS IN A TREATMENT POPULATION, IMPAIRED DRIVERS, AND DEATH INVESTIGATION CASES
BK Logan, AM Gordon
Washington State Toxicology Laboratory, Forensic Laboratory Services Bureau, Washington State Patrol, Seattle WA USA
Paper 4  THE CANNABIS INFLUENCE FACTOR (CIF)
T Daldrup
Institute of Legal Medicine, Heinrich-Heine-University, Düsseldorf, GERMANY
Paper 5  POPPY SEED CONSUMPTION AND TOXICOLOGICAL ANALYSIS OF BLOOD AND URINE SAMPLES
MR Moeller, K Hammer, O Engel
Institute of Legal Medicine, Saarland University, Homburg, Saarland, GERMANY
Paper 6  FIELD SOBRIETY TESTING, DRUGS OTHER THAN ALCOHOL, AND DRIVING PERFORMANCE: A MODEL FOR VALIDATION OF SFST
E. Ogden, K. Papafotiou, C. Stough, D. Sullivan
Drugs And Driving Research Unit, Centre For Neuropsychology, Swinburne University Of Technology, AUSTRALIA
Paper 7  PREVALENCE OF DRUGS IN VICTORIAN IMPAIRED DRIVERS
A Kotsos*, J Gerostamoulos*, M Boorman**, OH. Drummer*
*Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, Southbank, Victoria; **Victoria Police, Traffic Operations Group, Dawson St, Brunswick, AUSTRALIA
 
 Questions and Answers
 
18.00-  Free evening
 
18.00  Randox Laboratories workshop [free]
EVIDENCE® BIOCHIP ARRAY TECHNOLOGY WORKSHOP
Dr Paul Orsulak (Texas, USA)
La Trobe Room - refreshments provided
Please click for Randox Invitation card
 



SummaryMonday 17Tuesday 18Wednesday 19Thursday 20Fri. 21 - Sat. 22Poster sessions
 

TIAFT Home

41st International TIAFT meeting
Chairperson: Prof. Olaf H. Drummer (olaf@vifm.org)
Deputy Chairperson & Secretary: Dr. Jim Gerostamoulos (jimg@vifp.monash.edu.au)
Sponsorship & Events: Ms Mary Boratto (maryb@vifp.monash.edu.au)
Secretariat: Dr. Mick Gould, Convention Associates Pty Ltd
13 Jeffrey Street, Mount Waverley, 3149, Australia
Phone +61 3 9887 8003 - Fax +61 3 9887 8773 - convention@optushome.com.au